XML 35 R24.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders’ Equity (Tables)
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Summary of RSU Activity

For the three months ended March 31, 2024, a summary of RSU activity is as follows:

 

   Shares   Weighted Average Grant Date Fair Value 
Outstanding as of December 31, 2023   152,703   $18.03 
Granted        
Canceled   (463)   9.34 
Outstanding as of March 31, 2024   152,240    18.06 
Vested as of March 31, 2024   143,427    18.56 
Unvested as of March 31, 2024   8,813   $9.89 

For the three months ended March 31, 2023, a summary of RSU activity is as follows:

 

   Shares   Weighted Average Grant Date Fair Value 
Outstanding as of December 31, 2022   51,484   $46.22 
Granted   32,489    8.40 
Canceled   (2,861)   36.16 
Outstanding as of March 31, 2023   81,112    31.43 
Vested as of March 31, 2023   56,151    32.20 
Unvested as of March 31, 2023   24,961   $29.70 
 
Summary of Options Activity

For the three months ended March 31, 2024, a summary of the options activity is as follows:

 

   Shares   Weighted Average Exercise Price   Weighted Average Fair Value   Weighted Average Remaining Contractual Term (Years)   Aggregate Intrinsic Value 
Outstanding as of December 31, 2023   125,264   $40.61   $22.04    23.80   $45,880 
Granted                    
Exercised                    
Expired/Forfeited   (60,181)   41.09    22.51         
Outstanding as of March 31, 2024   65,083   $40.19   $21.63    2.36   $ 
Exercisable as of March 31, 2024   58,848   $43.68   $23.56    2.19   $ 
Schedule of Significant Weighted Average Assumptions

For the three months ended March 31, 2024 and 2023, the significant assumptions relating to the valuation of the Company’s stock options granted were as follows:

Schedule of Significant Weighted Average Assumptions 

   2024   2023 
   March 31, 
   2024   2023 
Stock price  $   $9.00 
Dividend yield   %   %
Expected life (years)       3.02 
Expected volatility   %   65.78%
Risk-free interest rate   %   3.81%